Literature DB >> 29667369

Fully Automated Production and Characterization of 64 Cu and Proof-of-Principle Small-Animal PET Imaging Using 64 Cu-Labelled CA XII Targeting 6A10 Fab.

Luise Fiedler1, Markus Kellner2, Rosel Oos1, Guido Böning1, Sibylle Ziegler1, Peter Bartenstein1, Reinhard Zeidler2,3, Franz Josef Gildehaus1, Simon Lindner1.   

Abstract

64 Cu is a cyclotron-produced radionuclide which offers, thanks to its characteristic decay scheme, the possibility of combining positron emission tomography (PET) investigations with radiotherapy. We evaluated the Alceo system from Comecer SpA to automatically produce 64 Cu for radiolabelling purposes. We established a 64 Cu production routine with high yields and radionuclide purity in combination with excellent operator radiation protection. The carbonic anhydrase XII targeting 6A10 antibody Fab fragment was successfully radiolabelled with the produced 64 Cu, and proof-of-principle small-animal PET experiments on mice bearing glioma xenografts were performed. We obtained a high tumor-to-contralateral muscle ratio, which encourages further in vivo investigations of the radioconjugate regarding a possible application in diagnostic tumor imaging.
© 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  64Cu; 6A10 Fab; Comecer Alceo; positron emission tomography; solid targets

Mesh:

Substances:

Year:  2018        PMID: 29667369     DOI: 10.1002/cmdc.201800130

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  2 in total

1.  Inhibitory Monoclonal Antibodies and Their Recombinant Derivatives Targeting Surface-Exposed Carbonic Anhydrase XII on Cancer Cells.

Authors:  Dovile Stravinskiene; Aiste Sliziene; Lina Baranauskiene; Vilma Petrikaite; Aurelija Zvirbliene
Journal:  Int J Mol Sci       Date:  2020-12-10       Impact factor: 5.923

2.  State of the Art in Radiolabeling of Antibodies with Common and Uncommon Radiometals for Preclinical and Clinical Immuno-PET.

Authors:  Marion Chomet; Guus A M S van Dongen; Danielle J Vugts
Journal:  Bioconjug Chem       Date:  2021-05-11       Impact factor: 4.774

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.